Antares Pharma’s (ATRS) stock has rocketed in the last two weeks from $2.88 September 20 to a current range near $3.90 at this writing, a gain of over 35%. Over the last 12 months, the stock is up 122%, from $1.75 to $3.89 currently. Such stellar gains bring into question the near and intermediate-term expectations for the stock. After writing several SA articles on the company, with the last in June, an update to the story is overdue.
